The wholesale acquisition cost (WAC) for Concerta varies. For instance, a 36 mg tablet of Concerta may have a WAC of approximately $278.07 for a 30-count bottle [1]. Similarly, a 27 mg tablet in a 30-count bottle can have a WAC of around $278.07 [1]. Other strengths, such as 18 mg and 54 mg, also have comparable WACs for a 30-count bottle, often around $278.07 [1].
How does Concerta's pricing compare to other ADHD medications?
The pricing of Concerta is influenced by factors such as dosage, quantity, and whether it is a branded or generic version. Generic versions of methylphenidate, the active ingredient in Concerta, are available and generally have lower WACs than the brand-name drug. For example, generic methylphenidate extended-release tablets can have significantly lower acquisition costs, with a 30 mg tablet potentially costing around $35.34 for a 30-count bottle [2].
When does Concerta's patent exclusivity expire?
Patent exclusivity for Concerta has largely expired, allowing for the availability of generic versions. While specific patent dates can be complex and subject to litigation, the market has seen the introduction of generic methylphenidate products. Information on specific patent expiries and associated exclusivity periods can be found through resources like DrugPatentWatch.com [3].
What is the difference between brand-name Concerta and its generics?
The primary difference between brand-name Concerta and its generic equivalents lies in their manufacturers and cost. Both contain the same active ingredient, methylphenidate, and are designed to deliver it in an extended-release formulation. However, generic manufacturers do not incur the same research and development costs as the originator, which typically allows them to offer their products at a lower price point. Regulatory bodies like the FDA ensure that generic drugs are bioequivalent to their brand-name counterparts.
Who manufactures Concerta and its generic alternatives?
Concerta is manufactured by Johnson & Johnson's subsidiary, Janssen Pharmaceuticals. Generic versions of methylphenidate extended-release tablets are produced by various pharmaceutical companies.
What are the potential reasons for price fluctuations in ADHD medications?
Price fluctuations for ADHD medications like Concerta can stem from several factors. These include the introduction of generic competition, changes in manufacturing costs, supply chain disruptions, and market demand. Patent expirations are a significant driver for price reductions as generic alternatives become available.
Where can I find detailed information on Concerta's pricing and patent status?
Detailed information regarding Concerta's wholesale acquisition costs, as well as its patent landscape and exclusivity periods, can be accessed through specialized pharmaceutical databases and resources such as DrugPatentWatch.com [3]. These platforms often track pricing trends, patent filings, and litigation that can impact drug availability and cost.
---
Sources:
1. https://www.goodrx.com/concerta
2. https://www.goodrx.com/methylphenidate-er
3. https://drugpatentwatch.com/